End-of-day quote
Philippines S.E.
06:00:00 2024-04-25 pm EDT
|
5-day change
|
1st Jan Change
|
161.5
PHP
|
0.00%
|
|
0.00%
|
0.00%
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Capitalization
1 |
1,936
|
1,740
|
1,750
|
1,306
|
1,343
|
1,544
|
Enterprise Value (EV)
1 |
1,726
|
1,728
|
1,735
|
1,300
|
1,356
|
1,579
|
P/E ratio
|
17
x
|
-72
x
|
33.3
x
|
-647
x
|
-58.1
x
|
721
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
255
x
|
224
x
|
208
x
|
167
x
|
168
x
|
556
x
|
EV / Revenue
|
227
x
|
222
x
|
206
x
|
166
x
|
170
x
|
569
x
|
EV / EBITDA
|
-44.7
x
|
-55.2
x
|
-64.2
x
|
-58.1
x
|
-53.5
x
|
-125
x
|
EV / FCF
|
6.03
x
|
-9.34
x
|
-17.2
x
|
-87.1
x
|
-287
x
|
-3.49
x
|
FCF Yield
|
16.6%
|
-10.7%
|
-5.82%
|
-1.15%
|
-0.35%
|
-28.6%
|
Price to Book
|
2.57
x
|
2.06
x
|
1.94
x
|
1.5
x
|
1.5
x
|
1.72
x
|
Nbr of stocks (in thousands)
|
10,297
|
10,297
|
10,297
|
10,297
|
10,297
|
10,297
|
Reference price
2 |
188.0
|
169.0
|
170.0
|
126.8
|
130.4
|
150.0
|
Announcement Date
|
5/2/18
|
5/2/19
|
8/17/20
|
6/2/21
|
5/13/22
|
4/18/23
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net sales
1 |
7.606
|
7.775
|
8.431
|
7.824
|
7.989
|
2.777
|
EBITDA
1 |
-38.6
|
-31.32
|
-27.04
|
-22.36
|
-25.34
|
-12.64
|
EBIT
1 |
-39.17
|
-31.9
|
-27.54
|
-22.39
|
-25.37
|
-12.68
|
Operating Margin
|
-515.02%
|
-410.29%
|
-326.69%
|
-286.19%
|
-317.59%
|
-456.42%
|
Earnings before Tax (EBT)
1 |
108.5
|
-23.52
|
64.45
|
-15.6
|
-25.34
|
-10.4
|
Net income
1 |
114.2
|
-24.17
|
52.56
|
-2.015
|
-23.1
|
2.145
|
Net margin
|
1,501.54%
|
-310.81%
|
623.37%
|
-25.75%
|
-289.18%
|
77.24%
|
EPS
2 |
11.09
|
-2.347
|
5.104
|
-0.1960
|
-2.244
|
0.2080
|
Free Cash Flow
1 |
286.2
|
-185.1
|
-100.9
|
-14.93
|
-4.723
|
-452.3
|
FCF margin
|
3,762.85%
|
-2,381.08%
|
-1,197.13%
|
-190.78%
|
-59.12%
|
-16,286.75%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
250.6%
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
5/2/18
|
5/2/19
|
8/17/20
|
6/2/21
|
5/13/22
|
4/18/23
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
13.8
|
34.5
|
Net Cash position
1 |
210
|
11.8
|
15.2
|
5.62
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-0.5439
x
|
-2.731
x
|
Free Cash Flow
1 |
286
|
-185
|
-101
|
-14.9
|
-4.72
|
-452
|
ROE (net income / shareholders' equity)
|
12.4%
|
-2.71%
|
6.68%
|
-1.75%
|
-2.64%
|
0.35%
|
ROA (Net income/ Total Assets)
|
-1.84%
|
-1.4%
|
-1.24%
|
-1.02%
|
-1.17%
|
-0.57%
|
Assets
1 |
-6,208
|
1,721
|
-4,245
|
197
|
1,973
|
-378.6
|
Book Value Per Share
2 |
73.10
|
81.90
|
87.50
|
84.80
|
87.10
|
87.40
|
Cash Flow per Share
2 |
20.40
|
1.140
|
1.480
|
0.5500
|
0.2700
|
2.970
|
Capex
|
-
|
0.03
|
0.34
|
-
|
-
|
51.5
|
Capex / Sales
|
-
|
0.39%
|
4.02%
|
-
|
-
|
1,856.11%
|
Announcement Date
|
5/2/18
|
5/2/19
|
8/17/20
|
6/2/21
|
5/13/22
|
4/18/23
|
|
1st Jan change
|
Capi.
|
---|
| 0.00% | 28.78M | | +5.14% | 103B | | -5.63% | 63.04B | | +39.52% | 39.06B | | +12.91% | 37.58B | | +7.41% | 33.24B | | +6.85% | 19.22B | | +12.86% | 16.83B | | +7.73% | 15.03B | | +16.93% | 14.96B |
Other Commodity Chemicals
|